Creo Medical Limited

LSE CREO.L

Creo Medical Limited Capital Expenditure for the year ending December 31, 2023: USD -1.53 M

Creo Medical Limited Capital Expenditure is USD -1.53 M for the year ending December 31, 2023, a 61.41% change year over year. Capital expenditure is cash spent on acquiring or maintaining fixed assets, such as property, plants, and equipment (PP&E).

Creo Medical Limited Capital Expenditure for the year ending December 31, 2022 was USD -3.96 M, a 52.24% change year over year.
Creo Medical Limited Capital Expenditure for the year ending December 31, 2021 was USD -8.28 M, a -953.21% change year over year.
Creo Medical Limited Capital Expenditure for the year ending December 31, 2020 was USD -786.59 K, a 46.89% change year over year.
Creo Medical Limited Capital Expenditure for the year ending December 31, 2019 was USD -1.48 M, a 16.23% change year over year.

Key data

Date	Capital Expenditure	Free Cash Flow	Depreciation And Amortization	Deferred Income Tax

LSE: CREO.L

Creo Medical Limited

CEO	Mr. Craig Jonathan Gulliford
IPO Date	Dec. 9, 2016
Location	United Kingdom
Headquarters	Unit 2, Creo House
Employees	278
Sector	Healthcare
Industries Medical Instruments 3D Printing Biotechnology Clinical Trials Hardware & Electronics

Description

Creo Medical Limited engages in the research and development of electrosurgical medical devices relating to the field of surgical endoscopy in the United Kingdom. It is developing Croma, an energy platform that powers a suite of multi-modal devices to optimize treatments for patients and physicians. The company also offers Speedboat Inject, an energy multimodality instrument for flexible endoscopy; Speedboat Slim, a flexible bipolar RF and microwave device for cutting and coagulation; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highlyperfused tissues. Creo Medical Limited was formerly known as MicroOncology Ltd. The company was incorporated in 2003 and is headquartered in Chepstow, the United Kingdom. Creo Medical Limited is a subsidiary of Creo Medical Group plc.

Key trends

Past 5 years